Back to Speakers
Dr. Michael Severino is the Chief Executive Officer (CEO) of Tessera Therapeutics. He joined Tessera in 2022 and brings more than two decades of biopharmaceutical leadership to the company. He also serves as a Flagship Pioneering CEO-partner and is currently leading the strategy behind research, development, and commercialization at Tessera.
Get the latest investment news and insights delivered straight to your inbox.